Contacter le RP

Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.


Babbler permet aux journalistes et communicants de collaborer plus simplement.

En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !

Leurs espaces presse sont sur Babbler :

Vous êtes à 1 clic de l'inscription !


Content de vous revoir !

Communiqué de presse

Recombinant Vaccines Market - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2026
timer minutes de lecture minute de lecture

Copier le lien
Recombinant vaccines market as compared to other regions due to highly organized livestock and major demand for livestock products in Europe.

Cliquez sur l'image pour obtenir le format original

The Recombinant Vaccines Market was valued at US$ 830.2 million in 2016 and is projected to expand at a CAGR of 6.0% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. There is an increase in awareness regarding prevention of vaccine preventable lethal diseases.

The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans and animals as well, which lead to the increased research & developments for the innovation of new and effective recombinant vaccines for the prevention of diseases. Government has also taken an initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing companies have also started some beneficial programs to provide vaccination free of cost to poor people, which creates a highly conducive environment for growth of the recombinant vaccines market in near future.

Request Sample Copy of the Business Report:

Detailed Segmentation

Global Recombinant Vaccines Market, By Product Type

Subunit Recombinant Vaccines,Attenuated Recombinant Vaccines,Vector Recombinant Vaccines,.

Global Recombinant Vaccines Market, By Disease Type

Infectious Disease,Cancer,Allergy,Others,.

Global Recombinant Vaccines Market, End User

Recombinant Human Vaccines,Animal Recombinant Vaccines,Poultry,Companion Animal Vaccines,Livestock,Porcine,Aquaculture Vaccines,.

The report segments the global recombinant vaccines market on basis of product type, end user, disease type and geography. On the basis of product type, the market is categorized into subunit recombinant vaccines, attenuated vaccines, and vector recombinant vaccines. Among these, the vector recombinant vaccines segment dominates the recombinant vaccines market throughout the forecast period. On the basis of disease type, the market is categorized into infectious disease, cancer, allergy, and others. On the basis of end user, the market is categorized into recombinant human vaccines and animal recombinant vaccines. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased awareness among people and increase in infectious and viral diseases.

Ask for customization:

Key features of the study:

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products,regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global Recombinant Vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
  • The global recombinant vaccines market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical devices companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the recombinant vaccines market

To know the latest trends and insights prevalent in the reprocessed medical devices, click the link below:

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,


Seattle, WA 98154

Tel: +1-206-701-6702


Visit our news Website:

  • Business
  • Communications & Marketing
  • Company News & Announcements
  • Health & Medicine
  • + 3
  • Medicine
  • Sales & Marketing
  • Science & Technology

Autres actualités de la marque

inscrit avec succès

Félicitations, vous êtes inscrit sur BABBLER !

Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !

Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici

  • Business
  • Communications & Marketing
  • Company News & Announcements